No Data
BEAUTYFARM MED (02373.HK) plans to hold a Board of Directors meeting on March 26 to approve the annual performance.
On March 14, Gelonghui announced that BEAUTYFARM MED (02373.HK) will hold a Board of Directors meeting on Wednesday, March 26, 2025, to review and approve the annual results of the company and its subsidiaries for the year ending December 31, 2024, and its release, as well as to consider a proposal for the payment of a final dividend (if any).
BEAUTYFARM MED: DATE OF BOARD MEETINGANDDATE OF PUBLICATION OF ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024
Are Strong Financial Prospects The Force That Is Driving The Momentum In Beauty Farm Medical and Health Industry Inc.'s HKG:2373) Stock?
Hong Kong stocks movement | BEAUTYFARM MED (02373) rose over 4% to create a new high for the year, after fully acquiring Nairia, which helps expand the Business territory.
BEAUTYFARM MED (02373) rose over 4%, reaching a new yearly high of HKD 17.88. As of the time of writing, it increased by 3.97%, priced at HKD 17.8, with a transaction amount of HKD 79.0756 million.
BEAUTYFARM MED (02373.HK) subsidiary subscribes for a capital-protected financial product worth 50 million yuan.
On December 13, Gelonghui reported that BEAUTYFARM MED (02373.HK) announced that on December 13, 2024, to effectively utilize idle funds, Peking Belishi (a subsidiary of the group) subscribed to a principal-protected financial product from Shanghai Pudong Development Bank with an investment amount of 50 million yuan.
Beautyfarm med (02373.HK) subsidiary subscribes to 0.15 billion yuan financial products.
Gelonghui November 27th, Beautyfarm Med (02373.HK) announced that on November 27, 2024, in order to effectively use idle funds, Hangzhou Liyan and Shenzhen Beautyfarm subscribed to guaranteed financial products from Industrial and Commercial Bank of China, with subscription amounts of RMB 80 million and RMB 70 million respectively.
Beauty Farm Medical and Health Industry Inc.'s (HKG:2373) 32% Jump Shows Its Popularity With Investors
